STUDY DESIGN: This is a secondary analysis of a prospective, multicenter, observational study that included women with prior CD (MFMU Cesarean Registry). Two groups of patients from the registry were studied: patients with MAP and patients with placenta previa regardless of MAP (PP). The exposure of interest was the number of prior CD: !2 CD compared to 1 CD. The primary outcome was PTD <34 weeks. Secondary outcomes included transfusion of blood products, preterm labor requiring hospitalization/tocolysis, NICU admission, and a composite of maternal and neonatal complications. Balance of maternal demographics in the two groups was assessed using two sample t-tests and chi-square tests, and potential confounders were included in multivariable logistic regression models. Backward selection was used to identify parsimonious models. RESULTS: The MAP analysis included 194 women, 97 (50%) of whom had 1 prior CD and 97 (50%) of whom had !2 prior CD. There was no increased risk of PTD <34 weeks in women with !2 prior CD in the setting of MAP (23.7% vs. 29.9%, p¼0.27). Only need for plasma transfusion was associated with !2 prior CD (29.9% vs. 17.5%, p¼0.04) ( Table 1 ). There were 776 women with PP, 667 (86%) with 1 prior CD and 109 (14%) with !2 prior CD. Similarly, there was no increased risk of PTD <34 weeks with !2 CD in the setting of PP (27.5% vs. 22.6%, p¼0.08). However, it was associated with a higher odds of need for transfusion and the maternal composite outcome (Table 2) . CONCLUSION: Women with MAP or PP who have had !2 prior CD did not appear to have a higher risk of complications or PTD<34 weeks. Those with !2 prior CD may have a higher risk of maternal complications including need for transfusion products that may be independent of timing of delivery.
309 The impact of a birth plan on maternal and neonatal delivery outcomes 
OBJECTIVE:
To evaluate the impact of a written birth plan on maternal and neonatal outcomes. STUDY DESIGN: This is a prospective, non-randomized controlled trial of low-risk women with and without a written birth plan who presented to labor and delivery at term. Each woman with a birth plan was matched sequentially with the next woman of similar age, body mass index, parity and spontaneous vs. induced labor pattern, but without a birth plan. Indices of maternal and neonatal outcome were then compared. RESULTS: Women in each group were demographically similar. There were no differences in the length of any phase or stage of labor. Women with a birth plan were 25% more likely to undergo cesarean delivery, although this difference did not reach statistical significance (24% vs. 18%, p ¼ 0.46 ) However, a longer birth plan was associated with a significantly higher rate of cesarean delivery (p ¼ 0.039.) Neonates of women with a birth plan had a statistically significant increase in the rate of meconium passage (26% vs. 10%, p ¼ 0.04), significantly greater arterial and venous base deficit (arterial -5.4 vs. -3.6, p ¼ 0.01), and significantly lower umbilical artery and vein pH values (arterial 7.23 vs. 7.28, p ¼ 0.004).
CONCLUSION: We could demonstrate no medical benefit to a written birth plan. However, a birth plan was associated with a significant increase in neonatal indices of intrapartum metabolic acidemia. A longer birth plan was also associated with a significantly higher rate of cesarean delivery. Maternal actions that modify standard care processes have the potential for harm, without medical benefit. Patients and providers should understand the potential for such effects of maternal birth plans on labor and neonatal outcomes.
Association of breastfeeding (BF) and IQ
Beth A. Plunkett STUDY DESIGN: We conducted a secondary analysis of a multicenter, double-blinded RCT in which women with a singleton pregnancy were identified prior to 20 weeks with subclinical hypothyroidism or hypothyroxinemia and treated with thyroxine or placebo. Treatment did not affect outcome so the 2 groups were combined for this analysis and infants with anomalies (chromosomal or structural) or admission for intensive care were excluded. Our primary outcome was low IQ score (<85 at age 5 by WPPSI-III). Secondary outcomes include DAS-II scores at age 3, Bayley III score (age 1 and 2), Child Behavioral Checklist (age 3 and 5), and Conners' Rating ScalesRevised ADHD scores (age 4). Duration of BF was self-reported 2 years after delivery. Univariable analyses were performed to compare maternal characteristics and child outcomes based on BF (any vs. none).
Step-wise backward proceeding logistic regression models were used to examine the association of BF (any vs. none, and duration) with neurodevelopmental outcomes, adjusting for maternal age, race/ethnicity, parity, education level, insurance, thyroid status, treatment group, gestational age at delivery, SGA birth weight, infant sex, and age at neurodevelopmental exam. Variables with a P-value <0.1 in the step-wise models were included in final regression models. RESULTS: Of the 772 women studied, 614 (80%) reported BF (Table  1) . Of these, 31% reported BF for <3 months, 20% for 4-6 months, 11% for 7-9 months, 15% for 10-12 months and 23% for >12 months. IQ scores were available for 756 children whose average age at exam was 60.1AE1.7 months. In univariable analysis, mean IQ scores were higher at age 5 with any BF (96.7AE15.1) than without (91.2AE15.0, P<0.001), and IQ <85 occurred less frequently after any BF (21.5%) than without BF (36.2%, P¼0.001). The final multivariable adjusted model for low IQ included BF, education, insurance and male sex. BF was associated with reduced odds of low IQ (aOR 0.62, 95% CI 0.41-0.93). In adjusted models, each month of BF was associated with lower risk of IQ<85 (aOR 0.967, 95% CI 0.939-0.996, P¼0.028). The only other significant association in the adjusted analyses was lower risk of DAS-II scores <85 at age 3 per month of BF (aOR 0.954, 95% CI 0.927-0.982, P¼0.0013). CONCLUSION: BF was associated with lower risk of IQ scores<85 at age 5. In a large prospective cohort study of nullipara, participants completed the Edinburgh Postnatal Depression Scale (EPDS) during the first trimester and again at the third study visit (between 22 and 29 6/7 weeks). In the midtrimester, between these depression assessments, a subgroup underwent actigraphy and completed a sleep diary for 7 days. A high EPDS score was defined as an EPDS score > 10 or any thoughts of self harm. Sleep disturbances were defined as follows: short sleep duration < 7 hours, high fragmentation index >75%ile, high wake after sleep onset (WASO) >75%ile, elevated sleep onset latency >30 minutes, low time above light threshold 1000 lux (TALT) <25%ile, low sleep efficiency <80%. Univariable analyses were performed to investigate the association between maternal baseline characteristics, sleep disturbances and high depression scores later in pregnancy. All significant (P<0.05) covariates in univariable analysis were included in multivariable analysis. RESULTS: The study population for this analysis includes 778 women who had visit 3 EPDS scores and who underwent actigraphy assessment. This cohort represented a racially and ethnically diverse group of women with an average age of 27 years (Table) . At visit 3, 108 (13.9%) women had high EPDS scores. Univariable analyses demonstrated that these women were significantly more likely to be younger, single, publicly insured, smokers, diagnosed with a mental health condition prior to pregnancy, and to have high EPDS scores at the first study visit as compared to women with low scores at visit 3. Women with elevated sleep onset latency and low-sleep efficiency were significantly more likely to have high EPDS scores at visit 3 (Table) . However, in multivariable logistic regression, only preexisting mental health conditions (OR 3.7, confidence interval 2.2-12.0) and high EPDS scores at the first visit (OR 7.7, confidence interval 3.4-17.5) remained associated with high EPDS scores at visit 3. CONCLUSION: Objectively-measured sleep disturbances in the middle of pregnancy were not independently associated with high depression scores later in pregnancy.
